Predict your next investment

Thousand Oaks Biopharmaceuticals company logo
HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
tobiopharm.com

See what CB Insights has to offer

Total Raised

$169.36M

Investors Count

18

Thousand Oaks Biopharmaceuticals Funding, Thousand Oaks Biopharmaceuticals Valuation & Thousand Oaks Biopharmaceuticals Revenue

3 Fundings

Thousand Oaks Biopharmaceuticals's latest funding round was a Series C for $61.42M on March 10, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/10/2021

Series C

$61.42M

$0.00B

((9.99x))

FY 1234

3

7/23/2020

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

1/1/2019

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

Date

3/10/2021

7/23/2020

1/1/2019

Round

Series C

Series B

Series A

Amount

$61.42M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

3

10

10

Thousand Oaks Biopharmaceuticals Investors

18 Investors

Thousand Oaks Biopharmaceuticals has 18 investors. GoldStone Investment invested in Thousand Oaks Biopharmaceuticals's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/23/2020

3/10/2021

2
Series B, Series C (2021)

Private Equity

China

7/23/2020

3/10/2021

2
Series B, Series C (2021)

Private Equity

China

3/10/2021

3/10/2021

1
Series C

Asset/Investment Management

China

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Investment Bank

Hong Kong

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Corporate Venture

China

First funding

7/23/2020

7/23/2020

3/10/2021

00/00/0000

00/00/0000

Last Funding

3/10/2021

3/10/2021

3/10/2021

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

2
Series B, Series C (2021)
2
Series B, Series C (2021)
1
Series C

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Private Equity

Private Equity

Asset/Investment Management

Investment Bank

Corporate Venture

Location

China

China

China

Hong Kong

China

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.